Search - tctmd.com

Displaying 1 - 5 of 5

Sort: Relevancy | Date

Reduction of Revascularization in Patients with Hypertriglyceridemia with Icosapent Ethyl: Insights from REDUCE-IT REVASC

Presentation SCAI 2020

Reduction of Revascularization in Patients with Hypertriglyceridemia with Icosapent Ethyl: Insights from REDUCE-IT REVASC

Presenter: Benjamin E. Peterson

May 21, 2020

Intermediate Left Main Disease Linked to Worse Outcomes: ISCHEMIA

News Conference News SCAI 2020

Intermediate Left Main Disease Linked to Worse Outcomes: ISCHEMIA

May 20, 2020

PCI at Ambulatory Surgical Centers: Quality Cannot Suffer, SCAI Says

News Conference News SCAI 2020

PCI at Ambulatory Surgical Centers: Quality Cannot Suffer, SCAI Says

May 18, 2020

Outcomes with Intermediate Left Main Disease on Coronary CT Angiography ISCHEMIA Intermediate LM Substudy

Presentation SCAI 2020

Outcomes with Intermediate Left Main Disease on Coronary CT Angiography ISCHEMIA Intermediate LM Substudy

Presenter: Sripal Bangalore

May 16, 2020

Icosapent Ethyl Lowers Revasc Rates Across the Board: REDUCE-IT Data

News Conference News SCAI 2020

Icosapent Ethyl Lowers Revasc Rates Across the Board: REDUCE-IT Data

May 15, 2020

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.